bioSeedin webinar - Enabling tools to accelerate development of SARS-CoV-2 therapy

Topic:  Enabling tools to accelerate development of SARS-CoV-2 therapy

Time:  Saturday, May 23, 2020 5:30 to 7:00pm PT

Speaker：Yinan Jiang,Ph.D. (Product Development Manager ACROBiosystems), Henry Ji, Ph.D. (Co-founder, CEO&President Sorrento Therapeutics)

This webinar will cover:

> The molecular mechanism of SARS-CoV-2 spike protein-mediated virus entry into host cell.

> The important role of SARS-CoV-2 spike protein in serological testing, vaccine and antibody therapeutics development for COVID-19.

> The 3-D structural studies of SARS-CoV-2 spike protein alone or in complex with antibodies.

> The characterization of SARS-CoV-2 spike protein glycosylation sites.

> The discoveries of mutations in RBD of SARS-CoV-2 spike protein and the implications for drug and vaccine design.

Organizers：SABPA (Sino-American Biotechnology and Pharmaceutical Professional Association) , ACROBIOSYSTEMS

17:30-17:35

Welcome to SABPA FTD Webinar, Hua Gong, Ph.D., SABPA FTD

17:35-18:05

Sorrento's approach to prevention and therapeutic intervention of COVID-19 Pandemic. Henry Ji, Ph.D., Sorrento Therapeutics

18:05-18:35

Critical role of SARS-CoV-2 Spike protein in developing drugs,serological tests and vaccines for COVID-19. Yinan Jiang, Ph.D., ACROBiosystems

18:35-19:00

Q&A,Moderators:Howard Pan, Hui Wang and Andrew Wang,SABPA FTD